Emergence, development, and future of cardio-oncology in China: cardiohypersensitivity, cardiotoxicity and the Kounis syndrome.
10.1097/CM9.0000000000000130
- Author:
Nicholas G KOUNIS
1
;
Ioanna KONIARI
2
;
Panagiotis PLOTAS
3
;
George D SOUFRAS
4
;
Grigorios TSIGKAS
1
;
Periklis DAVLOUROS
1
;
George HAHALIS
1
Author Information
1. Department of Cardiology, University of Patras Medical School, Rion, Patras, Achaia, Greece.
2. Department of Electrophysiology, Queen Elizabeth Hospital, Birmingham, England, United Kingdom.
3. Department of Public Health, School of Medicine, University of Patras, Greece.
4. Department of Cardiology, "Saint Andrews" State General Hospital, Patras, Achaia, Greece.
- Publication Type:Case Reports
- MeSH:
Afatinib;
therapeutic use;
Carcinoma, Squamous Cell;
drug therapy;
Cardiotoxicity;
China;
Cisplatin;
therapeutic use;
Coronary Artery Disease;
drug therapy;
Deoxycytidine;
analogs & derivatives;
therapeutic use;
Humans;
Kounis Syndrome;
drug therapy;
Male;
Medical Oncology;
statistics & numerical data;
trends;
Middle Aged
- From:
Chinese Medical Journal
2019;132(6):753-754
- CountryChina
- Language:English
